EFSA Approved Health Claims for Supplements

Introduction: The Credibility Problem in Supplements

Every day, consumers face a choice between products with vague claims (“supports immune health,” “boosts energy,” “detoxifies your body”) and products with specific, mechanism-based claims backed by human clinical trials, standardised dosages, and regulatory approval from Europe's most rigorous food authority.

The difference is not just quality. It is credibility.

The European Food Safety Authority (EFSA) evaluates health claims against a standard equivalent to pharmaceutical evidence review. If a supplement claim passes EFSA scrutiny, it has been assessed by independent scientific panels, supported by multiple human randomised controlled trials, and its decision published transparently.

This guide explains why EFSA matters, how the approval process works, which claims have been approved and rejected, and how to use EFSA standards to evaluate supplement quality.

Section 1: Why EFSA Exists

The US Approach: “Permitted Unless Proven Harmful”

The US Dietary Supplement Health and Education Act (DSHEA) of 1994 established a permissive framework: supplements are assumed safe unless proven otherwise; brands can make structure-function claims without pre-approval; no mandatory clinical trials before market entry; enforcement is reactive, not proactive.

The EU Approach: “Proven Before Permitted”

EU Regulation 1924/2006 established that health claims on foods (including supplements) must be:

• Pre-approved by EFSA before marketing
• Backed by human clinical evidence (not animal studies or in vitro data)
• Specific and mechanistic (not vague)
• Evaluated transparently (decisions published in full)
• Standardised to specific dosages (not “take as needed”)

EFSA's evaluation process takes 12–18 months, involves multiple external expert reviewers, includes a public commentary period, and publishes the full rationale for every approval or rejection.

Section 2: How EFSA Evaluates Health Claims

Step 1: Submission & Dossier Preparation

A brand or ingredient supplier submits a dossier containing: a literature review of all published studies, human clinical trials (preferably multiple RCTs), mechanism of action documentation, dosage justification, safety data (toxicology, adverse events, at-risk populations), bioavailability evidence, and standardisation methodology.

A dossier is typically 50–200 pages. Documentation preparation costs €50,000–150,000.

Step 2: Scientific Assessment

EFSA's expert panels ask:

• Is the evidence sufficient? (Enough human trials? Are they well-designed?)
• Is the claim specific? (Can it be measured and verified?)
• Is causation established? (Does the ingredient cause the effect?)
• Is the dosage justified? (Does it match doses used in trials?)
• Are there safety concerns?

Panels typically require 2–3+ human randomised controlled trials with objective primary outcome measures published in peer-reviewed journals.

Step 3: Risk Assessment

EFSA's Risk Assessment Division reviews safety data including toxicity at the claimed dosage, special populations (pregnant women, children, individuals on medications), drug interactions, and cumulative exposure risk.

Step 4: Published Decision

EFSA publishes the approval decision, full assessment document, risk assessment summary, and all submitted data. This transparency is radical compared to the US, where supplement claims are often unexamined by any public body.

Section 3: Why EFSA Approval Signals Quality

1. Human Clinical Evidence Exists

In vitro studies and animal studies do not qualify. EFSA requires human randomised controlled trials. Most supplement ingredients do not have even one RCT. EFSA-approved ingredients have multiple.

2. Dosage Is Research-Based, Not Guessed

An EFSA-approved claim comes with a specific dosage (e.g., “150 mcg iodine daily”). Brands cannot include tiny amounts and make the approved claim. The dose used in the claim must match the dose used in the supporting clinical trials.

3. Mechanism Is Documented, Not Assumed

EFSA does not accept “it's natural, so it must be healthy.” Example: “Iodine supports thyroid function” is approved because iodine is required for thyroid peroxidase enzyme function — a documented biochemical mechanism.

4. Safety Is Vetted for Real-World Use

EFSA approvals include safety conditions. For example, certain marine-derived polysaccharides include a note that they are not recommended for individuals on anticoagulant therapy, because sulfated polysaccharides show anticoagulant properties at high doses.

5. Decisions Are Transparent and Revisable

EFSA publishes every decision. If new evidence contradicts an approval, EFSA can revoke it. This creates ongoing accountability.

Section 4: Common EFSA Rejections

Claim: “Detoxifies the Body”

Claim: “Boosts Immunity”

Approved alternative: “Supports healthy immune function” for specific ingredients where trials show defined biomarker changes (IL-10, TNF-alpha, NK cell activation).

Claim: “Increases Muscle Mass”

Claim: “Supports Metabolism”

Section 5: EFSA Standards in Practice

Formulating to EFSA-Approved Dosages

Products designed around EFSA standards use dosages from EFSA-approved or clinically-validated research:

• Marine Iodine: 150 mcg daily — meeting EFSA and WHO standards for thyroid function
• Vitamin C: 80 mg daily (NRV) — contributing to normal collagen formation and iron absorption
• Iron: 14 mg daily (NRV) — contributing to normal oxygen transport and red blood cell formation

No proprietary blends. No sub-therapeutic doses. Research-backed quantities.

EFSA-Aligned Claims vs. Non-Compliant Claims

Third-Party Testing at Batch Level

EFSA approval requires documented potency, purity, and safety. Batch-specific testing should include:

• Potency verification (HPLC confirming active compound content)
• Heavy metals screening (arsenic, cadmium, mercury, lead)
• Microbial testing (E. coli, salmonella, listeria)
• Identity verification (confirms what's on the label is in the product)

Section 6: Evaluating Supplement Credibility

The Credibility Spectrum

When evaluating a supplement, consider where it sits:

Tier 1 (Highest Credibility): EFSA-approved or EFSA-aligned claims; specific dosages published; human clinical trials cited; batch-specific third-party CoA published; safety warnings for at-risk populations; no proprietary blends; ingredient sourcing transparent.

Tier 2 (Good Credibility): Specific dosages; some human research cited; general third-party certification; some safety information.

Tier 3 (Low Credibility):Vague claims (“supports wellness”); proprietary blends with undisclosed dosages; no clinical research cited; no third-party testing; no safety information.

Section 7: Frequently Asked Questions

If a supplement isn't EFSA-approved, does that mean it doesn't work?

Not necessarily. Many supplements with legitimate research behind them lack EFSA approval because the submission cost is not commercially justified, or the brand operates only in the US where EFSA approval provides no regulatory benefit. However, if a claim is EFSA-approved, it has undergone the most rigorous independent review available.

Can EFSA approvals change?

Yes. EFSA can revoke approvals if new evidence emerges showing harm or insufficient benefit. This is rare but has occurred with some botanical claims. The system remains live and responsive to emerging evidence.

What's the difference between EFSA approval and “scientifically proven”?

“Scientifically proven” means an effect is documented in peer-reviewed research. “EFSA-approved” means it is scientifically proven andmeets EFSA's specific evidence thresholds — multiple human RCTs, published and transparent. EFSA approval is the stricter standard.

Does the US have anything comparable to EFSA?

Not structurally equivalent. The FDA oversees supplements but cannot require pre-approval of claims. The FTC can prosecute demonstrably false claims but enforcement is slow and reactive. USP (United States Pharmacopeia) certification verifies manufacturing quality but not health claims.

Can brands outside the EU use EFSA-approved language?

Yes. The US does not prohibit EFSA-aligned claims. A brand selling globally that uses specific, mechanism-based claims aligned with EFSA standards demonstrates voluntary commitment to the world's highest regulatory standard for supplements — even in markets where it is not legally required.

Isn't EFSA too restrictive?

This reflects the core philosophical difference between EU and US regulatory frameworks. EFSA intentionally rejects vague claims like “boosts immunity” that are scientifically unfalsifiable. From a consumer trust perspective: one specific claim you can defend is more valuable than ten vague claims you cannot.

Section 8: Your Evaluation Checklist

When assessing any supplement:

1. Find the label. Look for specific dosages and specific claims.
2. Check the EFSA register. Is the claim for this ingredient at this dosage authorised under EU Regulation 432/2012?
3. Request a CoA. Does the brand publish a batch-specific Certificate of Analysis for heavy metals, potency, and microbial testing?
4. Assess the claims. Are they specific and mechanism-based, or vague?
5. Check for safety information. Are at-risk populations (thyroid conditions, anticoagulation therapy) clearly flagged?
6. Look for proprietary blends. If dosages are hidden, the brand is not operating to EFSA standards.